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Prevention of rupture of abdominal aortic
aneurysm (AAA), with its attendant morbidity and
mortality, is the primary driving force behind elec-
tive aneurysm repair. Since the first report of
endovascular repair of AAA by Dr Juan Parodi and
Dr Julio Palmaz, there has been a steadily escalating
interest in endoluminal grafting for exclusion of
aneurysms.1 In spite of improved results with open
AAA repair and an overall mortality close to 3% in
elective cases, the potential for lower morbidity and
mortality, shorter hospital stays, lower costs, and an
earlier return to normal activity has resulted in endo-
luminal repair being pursued with increasing enthu-
siasm.2,3 This approach has gained significant accep-
tance in the academic community despite relatively
short follow-up data from clinical trials. Recently,
the Ancure (Guidant Corporation, Menlo Park,
Calif) and AneuRx (Medtronic, Sunnyvale, Calif)
devices received approval by the Food and Drug
Administration (FDA). In 405 cases of successful
implantation, two cases of rupture, one on day 1 and
one at 14 months, were reported at recent FDA
hearings leading to the approval of the AneuRx
device.4 We report three new cases of AAA rupture
in patients previously treated with the AneuRx
device. All aneurysm ruptures occurred essentially
two years after implantation.
CASE REPORT
Patient 1. M. O. H. was an 87-year-old man with
a positive history of coronary disease, congestive heart
failure, cerebrovascular accident, and hypertension; at
85 years of age, he was referred for endoluminal repair
because of an asymptomatic 8.5-cm AAA. The aneurysm
was repaired at the Arizona Heart Institute in Phoenix
through the deployment of a 28 × 15-mm AneuRx
device with a 14-mm contralateral limb. The procedure
was complicated by left iliac dissection requiring deploy-
ment of a Symphony stent (Boston Scientific
Corporation, Watertown, Mass) to maintain limb paten-
cy. No endoleak was observed on a completion
angiogram. Seven months postoperatively, the patient
had a follow-up duplex scan and contrast computed
tomography (CT) that demonstrated no endoleak and
an aneurysm shrinkage from 8.5 to 6.5 cm. The details
of follow-up studies between 7 and 23 months are
unknown to us. The patient was seen at Seton
Northwest Medical Center 23 months after endograft
repair with abdominal and back pain. On admission,
blood pressure was 87/60 mm Hg. A noncontrast CT
scan demonstrated a large retroperitoneal hematoma
with an 8-cm AAA (Fig 1). Contrast was not given
because of a creatinine level greater than 2.0 mg/100
mL. The patient was taken promptly to the operating
room for repair of an obviously ruptured aneurysm. The
operation was technically difficult and resulted in 6 L of
blood loss. The abdomen was opened through a long
midline incision. A small amount of free peritoneal
blood and a large retroperitoneal hematoma were
encountered. The iliac arteries were dissected and
clamped. A Crawford clamp was positioned at the
supraceliac aorta. The retroperitoneum was opened, the
aorta was isolated, and an infrarenal aortic clamp was
placed. The aneurysm had ruptured anteriorly near the
site of the modular junction. When the aneurysm was
opened longitudinally, the main body of the endograft
was encased by firm, organized, intraluminal thrombus;
however, there was fresh thrombus overlying the modu-
lar junction. Beneath this fresh thrombus was the left
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iliac limb, which was disengaged from the main body of
the graft at the modular junction (Fig 2, A). There was
no definite plane between some areas of the thrombus
and the intima of the aortic wall. Removal of the graft
and adherent thrombus resulted in areas of complete
“endarterectomy” of the aortic wall with diffuse bleed-
ing from the underlying muscle of the aortic media.
There was no evidence of abnormal inflammatory
change of the aortic wall. Graft removal was accom-
plished by gentle traction and side-to-side movements.
Proximally, this removal of the inner layers of the aorta
extended to the renal arteries so that infrarenal clamping
was inadequate for hemostasis and the securement of the
proximal anastomosis. Suprarenal clamping was not
readily obtained because of a low, large superior mesen-
teric artery; therefore, supraceliac crossclamping was
necessary. Both distal iliac attachments were well incor-
porated and secure. No patent lumbar, inferior mesen-
teric artery (IMA), or other collateral vessels were
found. The aorta was reconstructed with a 16 × 8-mm
bifurcated Dacron graft. The proximal aortic anastomo-
sis was accomplished with the aid of a strip of polytetra-
fluoroethylene felt covering the entire anterior and lat-
eral surfaces. A separate length of a Dacron graft with a
6-mm diameter was interposed between the bifurcation
limb and the left hypogastric artery to provide pelvic
outflow, because a long iliac stent trapped its orifice. At
the completion of the procedure, the hemodynamics
were improved with a systolic blood pressure in the
range of 120 mm Hg; there was adequate urine output
and no evidence of coagulopathy. The operative time
was 4 hours. Use of the cell-saver allowed return of
2500 cc of the patient’s red blood cells. 
Postoperative evaluation of plain abdominal radi-
ographs shows angulation of the graft in the lateral view
(Fig 3). The anteroposterior (AP) view shows that the
limb markers have migrated out of the main body, and
a small area now lacks fabric overlap, signaling Type III
endoleak (Fig 4). The degree of endograft angulation
and the significance of the limb markers were not
appreciated until comparison was made with the ex vivo
specimen. Subsequent ex vivo dissection of the graft
from the aortic thrombus confirmed graft limb migra-
tion and lack of fabric overlap (Fig 2, B). The patient
developed acute renal and pulmonary insufficiency on
day 2 and died 10 days after operation of multisystem
organ failure.
Patient 2 R. S. is a 72-year-old man with a medical
history reflecting no serious comorbidities who under-
went treatment of a 5-cm asymptomatic aneurysm with an
AneuRx device at St Vincent’s Hospital in Indianapolis in
April 1997 (Fig 5, A). The operative note of that proce-
dure did not indicate the size of the device implanted. A
proximal aortic extender, as well as two distal iliac exten-
ders into the external iliac arteries, was required for com-
plete obliteration of all endoleaks. Extenders are modular
stent graft components. The patient’s 1-year follow-up
CT scan showed the device to be positioned properly
without the presence of endoleaks. There appeared to be
no decrease in the size of the aneurysm (Fig 5, B). Eleven
months later (23 months after implantation), the patient
was seen at Bloomington Hospital in Bloomington, Ind,
with a ruptured AAA. His vital signs on presentation to
the emergency department were stable (blood pressure,
125/76 mm Hg; heart rate, 88 beats per minute [bpm]).
A preoperative CT scan demonstrated a large retroperi-
toneal rupture in addition to an increase in the size of the
aneurysm to 7.5 cm (Fig 5, C). The patient became unsta-
ble. His blood pressure dropped to 80/40 mm Hg, and
his heart rate rose to 122 bpm. He was taken immediate-
ly to the operating room. 
The aneurysm was approached through a midline inci-
sion. There was blood in the peritoneal cavity and a large
retroperitoneal hematoma. Finger dissection in the vicini-
ty of the renal arteries allowed palpation of the device.
This served as a guide to the renal arteries and helped
avoid injury to the left renal vein. A clamp was placed
immediately distal to the renal arteries, a few millimeters
above the proximal aortic extender. The patient remained
hypotensive, and Fogarty clamps were placed on both
common iliac arteries to obtain rapid distal control, even
though they contained the stented limbs of the graft. The
patient’s hemodynamics improved with proximal and dis-
tal vascular control and volume resuscitation. The
aneurysm was opened, and the main body appeared to
have become separated from the aortic extender. This
extender was itself well incorporated into the aortic wall.
This separation and a resultant endoleak are presumed to
have resulted in the aneurysm rupture. The site of rupture
was on the left posterolateral aortic wall, immediately
above the bifurcation. The extender was secured with a
hemostat, and torque was applied circumferentially before
pulling caudad. The proximal extender was removed with-
out resultant injury to the aortic wall. In fact, the aortic
cuff used for constructing the proximal anastomosis incor-
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Fig 1. Noncontrast CT scan showing AAA with intralu-
minal device. Note the retroperitoneal hematoma con-
tiguous with the aneurysm.
porated 3 to 4 mm of aortic tissue previously covered by
the proximal stent graft. 
Both limbs of the stent graft were exposed intralumi-
nally and transected with wire cutters. Care was taken not
to fray the fabric. After removal of the distal vascular clamps,
a no. 4 Fogarty balloon catheter was passed distally through
the transected stent into the left iliac artery. There was no
resistance to passage of the balloon as it traversed the metal
stent, which had impressively restored its luminal configu-
ration despite the previous application of a Fogarty clamp.
After bilateral lower extremity thrombectomy through each
iliac stent graft, a bifurcated Dacron graft, measuring 20 ×
10 mm, was used for aortic reconstruction. The graft was
anastomosed to the infrarenal aorta and to both limbs of
the transected stent graft, which appeared well incorporat-
ed and secure in the iliac vessels. The distal anastomoses
incorporated the iliac arterial walls as well as the stent graft,
with its external support left intact. This choice of graft size
resulted in the best size match to the iliac stent grafts and
proximal neck. The operative time was 1 hour and 55 min-
utes. The use of the cell-saver allowed return of 750 cc of
the patient’s red blood cells.
Postoperatively, the patient had atrial fibrillation requir-
ing intravenous antiarrhythmic agents and eventual conver-
sion to oral medications. He was discharged home in 12
days with palpable pedal pulses. He continues to do well,
walking without claudication at 6-month follow-up. A CT
scan shows an intact aneurysm repair without evidence of
leakage or angulation at the distal anastomotic sites that
incorporate residual segments of the stent graft (Fig 5, D). 
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Fig 2. Explanted AneuRx device with ex vivo dissection. A, Penmarks indicate anatomic endo-
graft orientation. White paper insert demonstrates disengaged left iliac limb. B, Enlarged view
of disengaged limb shows lack of fabric overlap of graft components. Note the acute fresh
thrombus overlying the graft separation zone. This is the site of acquired Type III endoleak.
White paper insert contrasts the stent graft fabric and surrounding thrombus.
A
B
Patient 3. H. G. was an 83-year-old  man with a past
medical history significant for chronic obstructive pul-
monary disease, hypertension, hypothyroidism, and alco-
hol abuse who underwent AneuRx repair of his AAA at
Harbor-UCLA in Torrance, Calif, approximately 23
months before the present admission. The repair was com-
plicated by postoperative Type II endoleak from an acces-
sory left renal artery. Follow-up studies showed persis-
tence of this leak with outflow provided by a patent right
lumbar artery (R. A. White, verbal communication,
October 1999). A laparoscopic approach to ligation of the
accessory renal artery was considered and offered to the
patient; however, he refused further surgical or radiologic
attempts to treat his endoleak. The patient went to the
emergency department of South Austin Hospital with
severe abdominal and back pain and a systolic blood pres-
sure of 76 mm Hg. A CT scan of the abdomen was
obtained while the vascular surgeon was en route. This
scan demonstrated a large AAA whose precise dimensions
were obscured by the extensive retroperitoneal hematoma
and contrast extravasation into the abdomen (Fig 6). He
was taken immediately to the operating room and
explored through a midline incision. There was a small
amount of free blood within the peritoneal cavity, and a
large retroperitoneal hematoma was encountered. The
aorta was clamped at the supraceliac level, and the iliac
arteries were clamped distal to the easily palpable endo-
graft. The site of aneurysm rupture appeared to be on the
anterior surface. The aneurysm sac was opened and  very
loose; poorly organized thrombus was found and
removed. Although the endograft components were
appropriately coupled, manipulation of the device within
the aneurysm sac produced separation of the contralateral
limb from the body of the graft. The body of the graft,
including stent and fabric, was incised vertically with Mayo
scissors to the renal arteries. The entire stent graft was
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Fig 3. AneuRx graft, which has become angulated
because of longitudinal aneurysm shortening. Note the
anterior bowing of the stent graft. The modular junction
forms the apex of the bow and the point of graft separa-
tion, endoleak, and rupture. 
Fig 4. Three sets of radiopaque limb markers are seen.
The most inferior marks designate the top of the iliac limb.
These markers should reside between the other two sets of
markers. Note the inferior displacement. 
removed easily, although it was well incorporated proxi-
mally and distally. A large right inferior lumbar artery
showed significant backbleeding and was suture ligated.
An identifiable accessory renal artery was not found, but
incorporation of a small collateral vessel into the proximal
anastomosis cannot be excluded or verified with certainty.
A bifurcated 14 × 7-mm Dacron graft was anastomosed
proximally to the aorta at the renal artery level and to the
common iliac arteries distally. A strip of polytetrafluo-
roethylene felt was used to reinforce the anterior wall of
the proximal anastomosis. The patient bled diffusely as a
result of multifactorial coagulopathy characterized by
hypothermia, thrombocytopenia, and simple dilution of
coagulation factors from severe blood loss and large vol-
ume transfusion. He required more than 25 units of blood
and blood products intraoperatively, including 15 units of
packed red blood cells, 10 units of fresh frozen plasma,
platelets, and cryoprecipitate. This combination returned
his coagulation status to normal levels within the parame-
ters of prothrombin time, partial thromboplastin time,
platelet count, and fibrinogen level. The use of the cell-
saver allowed the return of 2100 cc of the patient’s red
blood cells. The operative time was 2 hours and 45 min-
utes. The patient also required large volumes of intra-
venous fluids postoperatively, but he eventually stabilized
at 36 hours. On day 3, he became hypotensive and hypox-
emic and became increasingly difficult to oxygenate
despite appropriate mechanical ventilation. The refractory
hypoxemia was suggestive of a right-to-left shunt, and an
echocardiogram confirmed an atrioseptal defect. Arterial
blood gases showed hypoxemia without carbon dioxide
retention or acidosis. The patient was also leukopenic and
thrombocytopenic. In spite of heightened intensive care,
he deteriorated steadily and died within 2 hours of respi-
ratory failure. In addition to adult respiratory distress syn-
drome, pulmonary embolus, pneumonia, and sepsis were
considered as possible causes for his abrupt deterioration.
Permission to perform an autopsy was declined. 
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Fig 5. A, Contrast CT scan before AneuRx repair. B, Contrast CT scan 12 months after
AneuRx repair. Note lack of change in aneurysm diameter. C, Contrast CT scan showing
large retroperitoneal hematoma extending superiorly beyond the body and proximal exten-
sion of graft. This image demonstrates a 2.5-cm increase in AAA size at an 11-month inter-





The current debate over open surgical versus
endoluminal treatment of AAA is beyond the scope
of these case reports. There is considerable contro-
versy over whether the latter approach will truly
reduce morbidity and mortality or whether shorter
hospital stays and a quicker return to normal activi-
ty are the only advantages of this technique. The lit-
erature is replete with reports documenting the
equivalency of endograft therapy to the standard
approach. However, long-term outcome data are
lacking, and durability has not yet been demonstrat-
ed.5 May et al6 reported a 3-year success rate of only
70%, as defined by continuing graft function with-
out endoleak or conversion to open repair, and
Walker et al7 reported a disappointing 11.3% 30-day
mortality rate for aortic endografting in 221
patients. Investigators are currently debating the
importance of device design, attachment stability in
the face of aortic wall evolution and remodeling,
endoleaks and their potential for calamity or closure,
associated costs, and many other issues that would
only serve to detract from the clinical focus of this
paper if discussed here. This report is intended to
contribute to the awareness of late aneurysm rup-
ture after implantation of the AneuRx device, its
possible mechanisms, and the lessons learned in
management of this disastrous complication. 
Incidence of AAA rupture after AneuRx
endograft placement. The initial report of the
phase II US AneuRx trial mentioned no ruptures.8
This position was held until April 1999.9 However,
in June 1999, FDA hearing transcripts indicate that
two ruptures were reported and discussed.4 One
occurred at 24 hours and was believed to represent
delayed recognition of an operative catheter injury.
The second one occurred at 14 months after a 12-
month follow-up duplex scan showed resolution of a
persistent endoleak seen on a 6-month CT scan. The
0.5% incidence (2/405) was considered low when
compared with the natural history of the disease. We
now report three other late ruptures occurring in a
relatively short period. All ruptures were beyond 23
months, but none had reached the 24-month mark
after implantation. All have been reported to the
manufacturer. At a recent meeting, Dr Zarins dis-
closed that nine ruptures are now known to have
occurred.10 These data have not yet been published.
We presume this number includes these three cases
because all of the implanting physicians were noti-
fied of the ruptures and each was an investigator in
the clinical trials. Also, all devices were returned to
the company for evaluation. Again, an incidence of
0.5% was projected and not considered high when
viewed against the natural history of the disease, not
the natural history of standard surgical repair.
However, this number of ruptures surfacing in only
6 months (June-November) is worrisome, particu-
larly because the ruptures are occurring late. Patients
1 and 2 reported here had follow-up radiologic
studies that showed no evidence of endoleak and
showed either AAA size reduction or no enlarge-
ment. Rupture, in spite of such encouraging follow-
up, has been reported by other authors.11 Late rup-
ture clearly argues for routine radiologic surveillance
well past 2 years, if not indefinitely, to ensure that
late endoleak or aneurysm enlargement has not
occurred. The late fate of aortic endografts is still a
critical issue, and there are numerous reports of late
ruptures to add doubt to the long-term success of
present devices.6,7,11-18
The mechanism of failure. The mechanism of
failure appears to be different, although possibly
related, in the three cases reported here. The AneuRx
endograft combines a self-expanding Nitinol stent
structure with a thin Dacron prosthesis and is
deployed over a guidewire. It has a modular (com-
ponent) design, consisting of a main aortouniiliac
body and a contralateral iliac limb that fit together to
function as a single unit to exclude aortic blood flow
from the aneurysm.8 In cases where endoleaks are
apparent at completion of the deployment of the
main body and contralateral limb, graft extenders can
be used either proximally or distally to create a seal.
Endoleaks can occur at the proximal or distal attach-
ment sites (Type I), or at the modular junctions due
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Fig 6. Contrast CT scan of Patient 3 at 23 months after
endograft implantation. Note large retroperitoneal
hematoma and extensive contrast extravasation into the
abdomen. Aneurysm size is approximately 7 cm in AP
dimension.
to separation of components (Type III).19,20 The lat-
ter was the cause of failure in Patient 1, and the for-
mer was the cause of failure in Patient 2. Thus, com-
ponent separation was involved in producing late
endoleaks and rupture in two of the three cases
reported here. In Patient 1, the contralateral limb
appears to have become disengaged from the main
body because of forces incurred during angulation
and shortening of the aneurysm sac over time. In
Patient 2, the proximal aortic extender became sepa-
rated from the main body of the graft, leading to
similar consequences. Patient 3 demonstrates a third
mechanism of failure that may or may not be related
to the particular endograft design. This patient had a
Type II endoleak, (ie, perigraft flow originating from
open collaterals communicating with the aneurysm
sac). This was present from the early postoperative
period to the time of rupture. Follow-up studies
demonstrated that the open collateral vessels were an
accessory renal artery and a lumbar artery. Three-
dimensional reconstruction of the raw CT data was
performed after rupture of the aneurysm in Patient
3. This was compared serially with previous three-
dimensional reconstructions and demonstrated an
increase in the lumbar-to-accessory renal artery flow
and an increase in aneurysm volume. The images also
showed the modular components to be appropriate-
ly overlapped (R. A. White, personal communication,
November 1999). It is presumed that the aneurysm
rupture was a result of an increase in aneurysm vol-
ume resulting from Type II endoleak from the patent
collateral vessels. It might be held that the AneuRx
design increases the risk of this type of endoleak in
that the “protected” inner fabric may be less likely to
incorporate into the aneurysm wall than an internal-
ly stented endograft. However, this is speculation.
The importance of persistent Type II endoleaks after
endoluminal repair has been widely debated. A poli-
cy of close observation has been recommended, but
if there is aneurysm expansion or persistence of the
endoleak for an extended period of time, it seems
reasonable to consider these leaks dangerous and in
need of standard repair.12  The outcome of our third
patient, who is said to have refused intervention,
clearly reinforces that point. 
Management of AAA rupture associated with
endograft repair. Operative conversion to the open
procedure after endografting is not a simple endeav-
or. As reported by May et al,21 there is considerable
mortality for patients with multiple severe comor-
bidities. They reported a 43% mortality for open
conversion in that population, and only one case was
for aortic perforation at the time of device place-
ment. Walker et al,7 from the United Kingdom,
reported a 100% mortality for five patients requiring
conversion to the open procedure; all patients had
immediate conversion. Clearly, conversion in the
face of aneurysm rupture adds greater hazards to the
patient than the technical difficulty of repair without
an indwelling endoluminal device. The difficulties
encountered in obtaining vascular control and in
dealing with an aorta that has lost much of its
integrity during the process of removing the endo-
graft makes surgical repair much more difficult than
in the setting of a “simple” ruptured AAA. Some
consider that the endograft might provide a partial
barrier to extravasation in the face of aneurysm rup-
ture and the patient is more likely to survive until
operative repair can be undertaken. This may be true
of some small endoleaks, but getting the patient to
the operating room and completing an open repair
does not guarantee a successful outcome, as reflect-
ed by our experience. Two of our three patients
died, and all were in shock. Including the other two
cases reported to the FDA, four of the five patients
we have knowledge of with this complication have
died within 4 months of technically successful con-
version. Nevertheless, certain observations and tech-
nical maneuvers in these three cases may contribute
to future management of this complication: aortic
wall changes produced by the endograft, gaining
proximal and distal control, the management of con-
comitant stents and extenders, and preserving ele-
ments of the device to simplify emergency operation.
The operation to explant the endograft and repair
the AAA in Patient 1 was quite difficult. With endo-
graft placement close to the level of the renal arteries,
removal of the graft resulted in removal of the subja-
cent layers of the aortic wall, much like an endarterec-
tomy. This left the aortic wall dangerously thin and
necessitated suprarenal and then supraceliac aortic
crossclamping, and the use of an extensive Teflon strip
to bolster the anastomosis. We presume that this diffi-
culty would not arise in the patient requiring immedi-
ate or early conversion because the graft will not have
had time to incorporate, thereby making its removal
less likely to destroy the aortic wall. Obtaining proxi-
mal control quickly and securely is critical in any rup-
tured aneurysm. Recommended juxtarenal placement
of these devices and the difficulties in extracting them
add to the challenge of vascular control. Supraceliac
clamping was required in two of our cases and may be
preferable in most. 
Adjunctive stenting, at the time of the original
procedure or subsequently, may introduce additional
difficulties. In this same patient (1), the left iliac sys-
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tem had required long segment stenting for dissection
at the time of the original procedure. This left the
hypogastric artery covered by an intraluminal stent.
Because the IMA was occluded at the time of original
repair and the right hypogastric artery was badly dis-
eased, it was necessary to completely excise the iliac
artery with the stent to construct the distal anastomo-
sis. An interposition graft from the bifurcated Dacron
graft to the left hypogastric artery was constructed to
preserve pelvic and colonic blood flow. 
The presence of stent extenders may create diffi-
culties. The presence of a proximal and two long dis-
tal (external iliac) extenders made the operation in
Patient 2 technically challenging. On the other
hand, this successful case demonstrates that less than
complete explantation of the endograft is a worth-
while option in some cases. Explantation of the
entire device, with all of its components, might have
led to the need for an aortobifemoral bypass, which
would have prolonged operative time and probably
increased postoperative morbidity. The decision to
retain part of the endograft will depend on whether
the attachment is stable and whether clamping the
stented ends to gain control has damaged their
integrity. The ability of the Nitinol structure to
return to its original configuration was impressive in
Patient 2. 
In conclusion, we present three new cases of late
rupture of AAA after AneuRx repair. These late fail-
ures, especially the two AAAs thought to be success-
fully repaired, suggest the need for indefinite radio-
logic surveillance at no more than 6-month inter-
vals, until the long-term performance of this device
is better defined. 
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